Havas Health named Anna Maria Marra as CEO of Europe on Tuesday morning, a role in which she will lead and oversee all ...

Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...

Both the FDA and EMA previously granted fast track and orphan drug designations to VCN-01 for the treatment ... Placed second of five finalists for Merck KGaA's EMEA Advance Biotech Grant which ...

Application error: a client-side exception has occurred (see the browser console for more information).

After Alexander Fleming’s initial discovery of the penicillium mould’s antibiotic ... collaboration including Merck, Pfizer and Squibb worked on mass producing the drug during World War ...

Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...

Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

Daiichi showed the mechanism can work in TGCT years ago, publishing phase 3 data in 2018 and winning FDA approval for Turalio ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Merck KGaA said its cell-tumor treatment Pimicotinib met its primary endpoint in a late-stage trial. The German pharma company said Tuesday that its experimental drug showed significant improvement in ...

The research also highlights potential avenues for repurposing existing drugs. Researchers found that trimethoprim and ...

Taking probiotics with antibiotics can help protect the gut from the negative effects of antibiotics. But some people may ...